Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

Cidara Therapeutics Inc. (CDTX)

  • Technical Exchange News
  • Jan. 08, 2026, 09:04 UTC
  • 32
  • 0 comments

NASDAQ symbol attribute type Test_mode was changed. Previous value: N. New value: Cidara Therapeutics, Inc. - Common Stock.

Comment Full text

Salarius Pharmaceuticals Inc. (SLRX)

  • Technical Exchange News
  • Jan. 08, 2026, 09:04 UTC
  • 29
  • 0 comments

NASDAQ symbol attribute type Security_Name was changed. Previous value: Salarius Pharmaceuticals, Inc. - Common Stock. New value: Salarius Pharmaceuticals, Inc. - Common Stock.

Comment Full text

FibroGen Inc (FGEN)

  • Technical Exchange News
  • Jan. 08, 2026, 09:04 UTC
  • 23
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: N. New value: FibroGen, Inc - Common Stock.

Comment Full text

Intelligent Bio Solutions Inc (INBS)

  • Technical Exchange News
  • Jan. 08, 2026, 02:56 UTC
  • 32
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

HCW Biologics Inc. (HCWB)

  • Technical Exchange News
  • Jan. 08, 2026, 02:56 UTC
  • 32
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Genprex Inc. (GNPX)

  • Technical Exchange News
  • Jan. 08, 2026, 02:56 UTC
  • 35
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Flora Growth Corp (FLGC)

  • Technical Exchange News
  • Jan. 08, 2026, 02:56 UTC
  • 37
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Barinthus Biotherapeutics Inc. (BRNS)

  • Technical Exchange News
  • Jan. 08, 2026, 02:56 UTC
  • 40
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

FibroGen Inc (FGEN)

  • Technical Exchange News
  • Jan. 08, 2026, 01:10 UTC
  • 35
  • 0 comments

NASDAQ traded attribute type Test_mode was changed. Previous value: N. New value: FibroGen, Inc - Common Stock.

Comment Full text

FibroGen Inc (FGEN)

  • Technical Exchange News
  • Jan. 08, 2026, 01:10 UTC
  • 37
  • 0 comments

NASDAQ traded attribute type Security_Name was changed. Previous value: FibroGen, Inc - Common Stock. New value: FibroGen, Inc - Common Stock.

Comment Full text
  • Previous
  • 165
  • 166
  • 167
  • 168
  • 169
  • Next

Search

News categories

  • Technical Exchange News(12372)
  • Event(6229)
  • SEC News(272208)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(158281)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin